This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
On Friday, the Food and Drug Administration (“FDA”) held its first public meeting during which stakeholders shared their perspective on how to regulate cannabidiol (“CBD”)-infused products. The objective of the meeting was to gather scientific data and information about the safety, manufacturing, product quality, marketing, labeling and sale of these products.
His med school refused to acknowledge the legality of medical marijuana. So a young doctor must learn from his patients. The post JAMA: Most Doctors Know Nothing About Cannabis appeared first on Leafly.
In July 2017, four medical cannabis patients joined other advocates in filing a lawsuit against the federal government in the U.S. District Court for the Second District of New York. The plaintiffs in the case (originally Washington v. Sessions , now Washington v. Barr ) sought a declaration that the placement of cannabis in Schedule I of the Controlled Substances Act was unconstitutional because it violates the Due Process Clause of the Fifth Amendment, protections guaranteed by the First Amend
Today, dozens of advocates from across the state of Delaware came together at Legislative Hall to support HB110 , a bill that seeks to legalize and regulate the sale of cannabis for adult-use in the First State. The House Revenue and Finance Committee was the first hurdle that HB110 needed to pass. Greatly outnumbering the opposition, Delawareans in favor of legalization stepped up and flooded the House chambers.
Speaker: Jonathan Bench, International Cannabis and Securities Business Attorney at Harris Bricken
The U.S. cannabis industry is still in its infancy, even though states began engaging with legalization in one form or another in the late 1990s. Today, many opportunities exist for individuals and businesses that want to engage in the industry. Some want to directly own licensed businesses, while others prefer to keep the industry at an arm’s length and merely profit from it.
The FDA is asking for input on how to regulate CBD and cannabis. Project CBD gave oral comments at last week’s public hearing, and we plan on submitting written comments and supporting documents to their public docket. You should, too.
Heading out of town? Now your cannabis can come along, too. In an update to its website’s “What Can I Bring?” section, the Travel Security Administration clarified that Food and Drug Administration-approved hemp products like certain CBD medications are now allowed in both carry-on and checked bags. The clarified language was quietly posted last week.
Heading out of town? Now your cannabis can come along, too. In an update to its website’s “What Can I Bring?” section, the Travel Security Administration clarified that Food and Drug Administration-approved hemp products like certain CBD medications are now allowed in both carry-on and checked bags. The clarified language was quietly posted last week.
Last week, Illinois became the 11th state to legalize cannabis for both medical and non-medical purposes. This move by Illinois is significant because it is the first state to legalize the adult use of cannabis through the legislature, rather than through a citizen initiative. By moving a legalization bill through its legislature, it is possible that Illinois will serve as a model for other states that are considering legalization, but may not wish to put the question before voters or may lack a
With the arrival of summer time in Kansas City, we want to welcome everyone to take part in our Summer Seminar Series. All of these FREE events will focus on rules and regulations of Amendment 2, now Article XIV, for patients and caregivers. These events will have a special topic each month and everyone will have time for Q&A. One of our main objectives for these seminars is to ensure patients have free resources and education around the new medical marijuana program.
“My name is Zoe Sigman, and I’m the Program Director at Project CBD , an educational nonprofit focused on cannabis science & medicine. Ten years ago, we introduced CBD to the medical cannabis community in California. It spread like wildfire and has become the hugely popular phenomenon that it is today.
Dr. Ethan Russo, a prominent cannabis researcher, weighs in on his theory of endocannabinoid deficiency—or the idea that many common illnesses might be caused by an unbalanced endocannabinoid system. The post Does Endocannabinoid Deficiency Play a Role in These Common Illnesses? appeared first on Leafly.
A split decision decided last Thursday, May 30, by the Second Circuit Court of Appeals reflects a lack of patience with U.S. Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. As most of our readers likely know, the Schedule of Controlled Substances, established by the Controlled Substances Act of 1970 (CSA), places marijuana in the most restrictive class, Schedule I, alongside heroin.
Photo: Buck Ennis/Crain’s New York Business. NORML is deeply saddened to report the untimely and tragic loss of longtime member and activist, Doug Greene. Doug served as Empire State NORML’s Legislative Director, and worked tirelessly to reform marijuana laws in the state of New York. “Doug was a passionate advocate for ending America’s failed war on cannabis consumers, and his work with NORML and for the cause spans decades not years.
EATONVILLE — Authorities say one person was shot in the leg after two people broke into a Washington state home containing an illegal marijuana growing operation. KOMO-TV reports two masked people barged into the Eatonville house early Tuesday. The Pierce County Sheriff’s Department says a fight erupted inside the home, resulting in one person getting shot.
Mushroom trips—which alter one’s sense of self, time, and space—have medical use in treating depression and PTSD, among other uses. The post Oakland City Council Decriminalizes Mushrooms, DMT, Ibogaine appeared first on Leafly.
As the cannabis industry has matured, the competition between businesses has increased exponentially whether engaged in the sale of recreational marijuana, hemp, or CBD. A significant risk for any ongoing or new venture arises at the end of a term of employment, whether that end is voluntary or involuntary. That risk is of a former employee starting a business that directly competes with your business, using knowledge and skills she acquired in your employ.
Every day NORML Chapters from around the country invest countless hours in advocating for meaningful marijuana law reforms on the local, state and federal level! Below is a brief rundown of some of their most recent accomplishments. NORML Announces Plans for 2019 Conference and Lobby Day. “This September, we invite you to join NORML members from across America to learn effective strategies, hear the latest scientific and political advancements, and meet in person with influential members o
Spokane — A Washington State University researcher and a Spokane budtender have at least one thing in common: They want more cannabis research. Mark Lange, WSU professor with the Institute of Biological Chemistry, published research in Plant Physiology on May 29 which differentiated nine strains of marijuana based on their chemical properties. The research identified terpenoids, which give the plant its aromatic qualities, commonly marketed by marijuana dispensaries as contributing to something
For those who love a fruity inhale from their cannabis, explore six strains and their berry-flavored terpenes. The post 6 Cannabis Strains for People Who Love Berry Terpenes appeared first on Leafly.
The NM Political Report | Medical Cannabis Program
JUNE 6, 2019
As expected, the head of New Mexico’s Department of Health approved opioid use disorder as a qualifying condition to use medical cannabis. In an announcement on Thursday, DOH Secretary Kathyleen Kunkel said she accepted a recommendation from the state’s Medical Cannabis Advisory Board to include opioid use disorder and five other conditions as reasons to grant a medical card for medical cannabis use.
Welcome to the latest edition of NORML’s Weekly Legislative Roundup! This week, the Appropriations Committee in the U.S. House of Representatives has for the first time included limited protections for cannabis businesses engaged in the legal marketplaces in 33 states. Governor Steve Sisolak (D) of Nevada signed legislation into law that prohibits certain employers from refusing to hire a worker because he or she tested positive for cannabis, as well as legislation encouraging financial in
We all know what being sick feels like. It often comes with having to take different medications, so that’s when we may ask ourselves: how does cannabis interact with other drugs? A seemingly harmless grapefruit can cause problems with your anti-anxiety medication, for example, so you can imagine what happens when more complex compounds interact.
It’s official: The Crunchwrap is losing ground to the blunt wrap. The post Americans Spent as Much on Cannabis as Taco Bell Last Year appeared first on Leafly.
Despite the May 31st BC Supreme Court ruling that again ordered Vancouver’s unlicensed dispensaries to close, Dana Larsen is keeping his dispensaries open for as long as possible. The Cannabis Life Network caught up with Dana Larsen, a prominent cannabis advocate and owner of The Medicinal Cannabis Dispensary, who told us why. CLN: How will […].
On June 19, 2019, at 1:30 PST, the Washington State Bar Association’s Cannabis Law Section will be presenting an online CLE on hemp. I’ll be joined by my esteemed colleagues to shed some light on hemp laws both nationally and here in the Evergreen State. You can register to join us here. We’ll cover a host of topics, but will start with the 2014 Farm Bill, which first allowed for the legal cultivation of industrial hemp for research purposes.
By: Jessica Wasserman and Nabil Rodriguez. After a ten hour marathon public hearing in Washington D.C. on Friday, one thing is clear: there is an urgent need for FDA to regulate and provide certainty for the already-existing CBD marketplace. The ball is now in FDA’s court as Congress watches to see whether FDA will move forward, as it has committed to Congress in several hearings over the past months.
A Colorado study finds that nearly half of all seniors enjoyed legal cannabis last year: some medically, some recreationally, some for both. The post Seniors Are Erasing the Line Between Medical & Recreational Cannabis Use appeared first on Leafly.
There are many reasons to love CBD, and the fact that it likely won’t show up on a drug test is just one of them. That doesn’t mean though, that those that enjoy a little CBD oil now and then don’t have any reason to worry. Continue reading → The post Does CBD Show Up in a Drug Test? appeared first on MSNL Blog.
Thining about using CBD oil for inflammation? That’s great! Here are seven other surprising CBD oil health benefits that’ll blow your mind! CBD oil has become a huge favorite for natural alternatives to healing in recent years. Those advocating for more natural alternatives to treatments have used CBD oil for inflammation, among other things.
Cannabis businesses use non-disclosure agreements (NDAs) constantly. This may be due to a combination of factors: 1) the relative hardship of acquiring and protecting intellectual property over marijuana-related processes and products, today and historically; 2) a general modus operandi of “close to the vest” dealings in an industry that historically was pushed underground; and 3) the fact that most cannabis businesses are small businesses which have not taken steps to formally register (registr
The New York senator says she'd work with Congress to decriminalize adult-use cannabis, tax nonprescription products, and use proceeds to aid communities harmed by the drug war. The post This 2020 Presidential Hopeful Actually Has a Legalization Plan appeared first on Leafly.
By: Madeleine Balestrier. Are you sick of your medicine cabinet feeling like a pharmacy? Do you have frustratingly chronic pain? Do you struggle with anxiety? All of the above? RELATED: How I Used CBD & THC Tinctures To Stop Anxiety From My Stressful Job. Try CBD oil! No, cannabidiol (CBD) oil won’t get you stoned, but the research claims it has the potential to leave you pain-free without all of the side effects and chemicals that come along with those little pill bottles that litter our m
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content